Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02075437
Other study ID # Pro00043556
Secondary ID MH097959
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date March 2014
Est. completion date September 2020

Study information

Verified date August 2020
Source Duke University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will provide tools to develop and pilot an intervention for Functional Abdominal Pain (FAP) using a ten session intervention with children ages 5-8. Investigators will train the subjects to be "Feeling and Body Investigators". During treatment phases the following will occur 1) gather clues (learn), 2) investigate (experience: perform interoceptive mystery missions to explore a body sensation), 3) organize body clues (contextualize: recall other contexts that evoke similar sensations), and 4) go on increasingly daring missions (challenge: decrease avoidance and safety behaviors). The FBI intervention will be developed and refined in 26 child-caregiver dyads during the current R21 phase. In the R33 phase investigators will randomize 100 subjects with FAP to FBI or an active control group in order to conduct a pilot-test of the feasibility, acceptance, and clinical significance of FBI. Young children with FAP who complete the FBI early intervention will learn to experience changes in the viscera as fun and fascinating, rather than scary, and will develop new capacities for pain management, adaptive functioning, and emotion regulation. For the R21 Phase (assessing initial feasibility) investigators hypothesize that ≥ 80% of participants enrolled in FBI will complete treatment and that ≥ 80% of participants will complete home-based practice assignments.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 126
Est. completion date September 2020
Est. primary completion date September 2020
Accepts healthy volunteers No
Gender All
Age group 60 Months to 107 Months
Eligibility Inclusion Criteria:

- Child is between 60 and 107 months old.

- Parent/legal guardian is present at the clinic visit who speaks English

- Child screens positive for recurrent abdominal pain by having: 1) 8 episodes of abdominal pain over 2 months (based on Rome III criteria), or 2) 2 or more episodes of abdominal pain which are causing an incapacity greater than or equal to 25% of the time in the past two months).

- Based on pediatric medical assessment, child meets criteria for functional abdominal pain (FAP) based on absence of other organic causes of recurrent abdominal pain.

- Consent given by caregiver and assent by child to participate.

- Presence of internet access, including that accessed by cell phone with video capabilities.

Exclusion Criteria:

- The index child being known to have mental retardation (IQ < 70) or other pervasive developmental disorders.

- Subject has a sibling who is already enrolled in our study. ***Possible Exclusion***

- Parent/ guardian who would be participating in the study is pregnant.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Feeling and Body Investigators with Functional Abdominal Pain
Investigator's ten session intervention trains children to be "Feeling and Body Investigators". Half of the sessions will be done in clinic and half at home via web-camera to facilitate generalization. During the treatment child/caregiver dyads will 1) gather body clues (Learn), 2) investigate (Experience: perform interoceptive mystery missions to explore a body sensation), 3) organize body clues (Contextualize: recall other context that evoke similar sensations), and 4) go on increasingly daring missions (Challenge: decrease avoidance and safety behaviors). If successful, young children with FAP who complete the FBI early intervention will learn to experience changes in the viscera as fun and fascinating, rather than scary, and will develop new capacities for pain management, adaptive functioning, and emotion regulation.
Treatment Strategies
identify strategies with unique patterns of neural circuit maturation associated with early visceral pain on the gut-brain axis: adapt acceptance-based behavioral strategies used to address psychopathology in older children to younger children; incorporate caregivers as role models and facilitators based on attachment research.

Locations

Country Name City State
United States Duke Children's Primary Care Picket Road Durham North Carolina
United States Duke University Young Child Lab at Brightleaf Square Durham North Carolina

Sponsors (1)

Lead Sponsor Collaborator
Duke University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants Who Complete Treatment Treatment in this study refers to10 treatment sessions (4 via webcam or over cell phone video chat from the subject's home and 6 in the investigator's lab) using an acceptance-based behavioral treatment for children 5 through 8 years old with impairing functional abdominal pain. This intervention is rooted in a biopsychosocial framework incorporating advances in neurodevelopment, behavioral learning theory, and attachment theory. 1.5 Years
Primary Percentage of Participants Completing Homework Assignment Enrollees will engage in assigned home-based practice sessions for at least nine of the ten treatment weeks. Completion of assigned practice sessions within a given week is defined as success. 1.5 Years
See also
  Status Clinical Trial Phase
Completed NCT03558009 - Epidemiological Analysis for Hereditary Angioedema Disease
Completed NCT03252743 - ICBT for Pain-predominant FGIDs in Children and Adolescents: an Implementation Study. N/A
Completed NCT03901560 - Music Therapy: Sickle Cell and Pain Crisis
Completed NCT02389998 - Efficacy of Open Label Placebo in Children With FGIDs N/A
Withdrawn NCT01269671 - Efficacy of Combination Therapy vs Placebo for Pediatric Functional Abdominal Pain Phase 1
Recruiting NCT03823742 - Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program? N/A
Completed NCT01118988 - Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents N/A
Completed NCT00876291 - Efficacy of Lactobacillus GG (LGG) in Children With Abdominal Pain N/A
Completed NCT04922476 - Effect of 35624® Alflorex® in Functional Gastrointestinal Disorders (FGIDs) in Children. N/A
Recruiting NCT01675050 - A Placebo-controlled Crossover Trial Using Cyproheptadine To Treat Children With Functional Abdominal Pain Phase 2
Active, not recruiting NCT02920268 - Just in TIME - Intervention With Dance and Yoga for Girls With Recurrent Abdominal Pain N/A
Completed NCT02113605 - Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders N/A
Completed NCT02872961 - SIBO, Immune Activation, and FGIDs in Children
Completed NCT00327548 - Use of Guided Imagery for Functional Abdominal Pain in Children: Phase 3